QA: Enfusion Inc in us_software/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001868912_2023_Enfusion_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning No stock price available subcommand.plot {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001868912')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001868912, Enfusion Inc

  xvar xval
0 LiabilitiesCurrent 17,380,000
1 LongTermDebt 2,959,000
2 remainder_Liabilities 0
3 IntangibleAssets 6,732,000
4 AssetsNoncurrent 4,484,000
5 AssetsCurrent 96,808,000
6 PropertyPlantAndEquipmentNet 15,759,000
7 remainder_Assets 0
8 SellingAndMarketingExpense 29,286,000
9 GeneralAndAdministrativeExpense 68,764,000
10 ResearchAndDevelopmentExpense 0
11 remainder_Expenses 65,337,000
12 remainder_Revenues 150,349,000
13 remainder_NetIncome -225,000
14 remainder_ComprehensiveNetIncome 5,430,000
  yvar yval
0 Liabilities 20,339,000
1 Assets 123,783,000
2 Expenses 163,387,000
3 Revenues 150,349,000
4 StockholdersEquity 103,444,000
5 NetIncome -13,263,000
6 ComprehensiveNetIncome -7,833,000
7 BaseVar 231,756,500
8 EconomicCapitalRatiobeforeLimitedLiability 4.63
9 EconomicCapitalRatio 5.62

Edgar->Model Mapping

Feature Distribution

Change over Time